Cargando…

A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties

INTRODUCTION: Activation of cyclooxygenase (COX)/prostaglandin and nuclear factor κB (NFκB) pathways can promote breast tumor initiation, growth, and progression to drug resistance and metastasis. Thus, anti-inflammatory drugs have been widely explored as chemopreventive and antineoplastic agents. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kastrati, Irida, Litosh, Vladislav A., Zhao, Shuangping, Alvarez, Manuel, Thatcher, Gregory R. J., Frasor, Jonna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632459/ https://www.ncbi.nlm.nih.gov/pubmed/26530254 http://dx.doi.org/10.1186/s12885-015-1868-7

Ejemplares similares

PHLDA1 Expression is Controlled by an Estrogen Receptor (ER)-NFκB-miR-181 Regulatory Loop and is Essential for Formation of ER+ Mammospheres
por: Kastrati, Irida, et al.
Publicado: (2014)

Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors
por: Semina, Svetlana E., et al.
Publicado: (2022)

An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors
por: Huang, Lei, et al.
Publicado: (2011)

Aspirin inhibits LPS-induced macrophage activation via the NF-κB pathway
por: Liu, Yitong, et al.
Publicado: (2017)

Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells
por: Semina, Svetlana E., et al.
Publicado: (2022)

Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer
por: Zhu, Yingdong, et al.
Publicado: (2017)

Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
por: Siklos, Marton I, et al.
Publicado: (2013)

Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus
por: Chen, Jingyu, et al.
Publicado: (2017)

Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells
por: Zeng, Yan-Ping, et al.
Publicado: (2016)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
por: Wu, Lili, et al.
Publicado: (2019)

Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells via the NF-κB Signaling Pathway
por: Zhang, Xi, et al.
Publicado: (2021)

THU480 Loss Of Selenof And A Western Diet Promote Mammary Tumorigenesis
por: Flowers, Brenna, et al.
Publicado: (2023)

Raloxifene and Desmethylarzoxifene Block Estrogen-Induced Malignant Transformation of Human Breast Epithelial Cells
por: Kastrati, Irida, et al.
Publicado: (2011)

Evidence for colorectal cancer cell specificity of aspirin effects on NFκB signalling and apoptosis
por: Din, F V N, et al.
Publicado: (2004)

Full Antagonism of the Estrogen Receptor without a Prototypical Ligand Side Chain
por: Srinivasan, Sathish, et al.
Publicado: (2016)

Emerging Roles of Ceramides in Breast Cancer Biology and Therapy
por: Pal, Purab, et al.
Publicado: (2022)

Low-Dose Aspirin Prevents Kidney Damage in LPS-Induced Preeclampsia by Inhibiting the WNT5A and NF-κB Signaling Pathways
por: Li, Guanlin, et al.
Publicado: (2021)

Distinct Roles of SELENOF in Different Human Cancers
por: Flowers, Brenna, et al.
Publicado: (2023)

Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
por: Zakaria, Norashikin, et al.
Publicado: (2018)

Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
por: Jiang, Wei, et al.
Publicado: (2020)

Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells
por: Deng, Peng, et al.
Publicado: (2016)

Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells
por: Deng, Peng, et al.
Publicado: (2019)

The NF-κB Pathway and Cancer Stem Cells
por: Rinkenbaugh, Amanda L., et al.
Publicado: (2016)

To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator
por: Sorriento, Daniela, et al.
Publicado: (2012)

Effect of Aspirin on the Expression of Hepatocyte NF-κB and Serum TNF-α in Streptozotocin-Induced Type 2 Diabetic Rats
por: Sun, Xiaodong, et al.
Publicado: (2011)

Aspirin alleviates hepatic fibrosis by suppressing hepatic stellate cells activation via the TLR4/NF-κB pathway
por: Liu, Yan, et al.
Publicado: (2020)

Aspirin-triggered lipoxin A(4 )attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells
por: Wang, Yan-Ping, et al.
Publicado: (2011)

Aspirin down Regulates Hepcidin by Inhibiting NF-κB and IL6/JAK2/STAT3 Pathways in BV-2 Microglial Cells Treated with Lipopolysaccharide
por: Li, Wan-Ying, et al.
Publicado: (2016)

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023)

Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma
por: Wang, Tianjiao, et al.
Publicado: (2019)

NF-κB promotes the stem-like properties of leukemia cells by activation of LIN28B
por: Zhou, Jianbiao, et al.
Publicado: (2018)

Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors
por: Smart, Emily, et al.
Publicado: (2022)

Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN/AKT/NF-κB/survivin signaling pathway
por: Jin, Mingji, et al.
Publicado: (2018)

Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo
por: Nath, Niharika, et al.
Publicado: (2015)

The Transcription Factor NF-κB in Stem Cells and Development
por: Kaltschmidt, Christian, et al.
Publicado: (2021)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

In vitro evaluation of cancer-specific NF-κB-CEA enhancer–promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines
por: Guo, X, et al.
Publicado: (2007)

Inhibition of Osteoblast Functions by IKK/NF-κB in Osteoporosis
por: Chang, Jia, et al.
Publicado: (2009)

IIV-6 Inhibits NF-κB Responses in Drosophila
por: West, Cara, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jad32554e4s424rrmvj3o6fof1